Dr Eduardo (Eddy/Eddie) Perez, PhD is the Chief Scientific Officer at Signum Biosciences and a scientific lead behind Epicutis®. He earned his PhD in Biochemistry and Molecular Biology from Rutgers University, with research focused on signal transduction. Dr Perez has more than a decade of experience across biotech and R&D, with expertise spanning dermatology-focused scientific development, evaluation of novel compounds, and formulation science for skin-focused applications.
In this episode of Doctor Diaries, live from Melbourne’s ASCPD Conference, Dr Eddy Perez joins Hanya Oversby to unpack the science lens behind modern skincare innovation — from how skin barrier biology shapes real-world routines, to why formulation choices matter just as much as headlineingredients.
We’ll explore how scientific teams assess new compounds, what “skin resilience” means in practical terms, and what clinicians should listen for when separating meaningful innovation from marketing noise.
For more information on Dr Perez, click here
https://www.linkedin.com/in/eduardo-perez-9b5a947/
More information about Hanya Oversby can be found on
#dreduardoperez #eddieperez #epicutis #signumbiosciences #ascpd.org.au#medicalworld #doctordiariespodcast #hanyaoversby #podcast #medicalbusiness #doctorsofinstagram#aestheticworld #doctor #secretsource #medicalpodcast
Doctor Diaries is a podcast series designed for healthcare professionals, featuring in-depth interviews with experienced clinicians across medical aesthetics, dermatology, surgery, and integrative medicine. Each episode provides insights into clinical approaches, practice development, and the realities of patient care in today’sregulatory landscape.
This content is intended for qualified healthcare professionals only and may discuss prescription-only products, regulated procedures, and clinical experiences not suitable forgeneral public promotion. Always refer to relevant professional guidelines and product information.